Clinical trial
The Safety and Efficacy of an Investigational Drug in Delaying the Progression…
NCT00006187 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00006187 |
|---|---|
| Title | The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alzheimer Disease |
| Intervention type | Drug |
| Interventions | Investigational drug |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Aug 28, 2000 |
| Last update posted | Dec 11, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: